Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00297895 · ClinicalTrials.gov registry record · NA
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
A NA study, sponsored by Saint John's Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 1,939
- Enrollment target
NCT00297895: Completed NA study, sponsored by Saint John's Cancer Institute.
NCT00297895 is a NA study that has completed, run by Saint John's Cancer Institute. The registered enrollment target is 1,939 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00297895, a NA study, has completed, sponsored by Saint John's Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,939 participants
- Enrollment target
Study Summary
Subjects must be diagnosed with melanoma. All subjects receive sentinel lymphadenectomy. If the subject is sentinel node positive and meets study requirements, the subject is randomized to receive either (1) completion lymphadenectomy (2) observation with nodal ultrasound. Subjects are then followed for 10 years.
Interventions
- PROCEDURE Completion Lymphadenectomy
- PROCEDURE Monitoring with nodal ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,939 participants |
| Start Date | 2004-09-30 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT00297895 record still lists
NCT00297895 is an interventional study that assigns participants to a tested intervention. Its 1,939 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% higher).
The record links to 0 conditions, and to 2 interventions - of which Completion Lymphadenectomy is the first listed.
NCT00297895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00297895 about?
NCT00297895 is a clinical study titled "Multicenter Selective Lymphadenectomy Trial II (MSLT-II)". Subjects must be diagnosed with melanoma. All subjects receive sentinel lymphadenectomy. If the subject is sentinel node positive and meets study requirements, the subject is randomized to receive either (1) completion lymphadenectomy (2) observation with nodal ultrasound. Subjects are then followed...
What is the current status of trial NCT00297895?
This trial is currently completed. It is a NA study. The enrollment target is 1,939 participants. The study started on 2004-09-30. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT00297895?
The interventions under investigation include: Completion Lymphadenectomy (PROCEDURE), Monitoring with nodal ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT00297895?
This trial is sponsored by Saint John's Cancer Institute, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00297895's enrollment target sits among peer trials
1,939 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI